Leaders | The war in Ukraine

Stay cool on Kherson

Why Ukraine’s army should not rush to recapture the whole province

Ukrainain soldiers are driven to their posotion in the Mykolaiv region of southern Ukraine, a few miles from the Russian lines in the Kherson region, on Thursday, Aug. 11, 2022. Despite recent pronouncements by Ukraine's leadership about the military's success along the Kherson front, troops have barely moved for weeks. (Daniel Berehulak/The New York Times)Credit: New York Times / Redux / eyevineFor further information please contact eyevinetel: +44 (0) 20 8709 8709e-mail: info@eyevine.comwww.eyevine.com

In the years to come, nato armed forces will queue at the door of Ukraine’s general staff to learn from the commanders who halted the Russian army’s march on Kyiv and Odessa and inflicted more than 60,000 casualties in six months of war. Yet a huge test still lies ahead: Ukraine wants its territory back.

This article appeared in the Leaders section of the print edition under the headline “Stay cool on Kherson”

Walkies

From the August 20th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights